@article{97775b02b43e476bb3381fba48f75f31,
title = "Inhibition Predicts the Course of Depression and Anxiety Symptoms among Adolescents: The Moderating Role of Familial Risk",
abstract = "Numerous theoretical models suggest that inhibition difficulties - the inability to moderate automatic responses - contribute to the onset and/or maintenance of internalizing symptoms. Inhibition deficits and internalizing disorders run in families and share overlapping genetic risk factors, suggesting that inhibition deficits may be particularly prognostic of internalizing symptoms in those with high familial risk. This study tested this hypothesis in a longitudinal sample during the transition from adolescence to early adulthood. As hypothesized, prospective associations between inhibition and anxiety and depressive symptoms 8 years later were moderated by familial risk for depression. Specifically, poorer inhibition prospectively predicted greater anxiety and depressive symptoms in those at high (but not low) familial risk for major depressive disorder. These findings provide preliminary support for impaired inhibition as an indicator of risk for later internalizing symptoms in those at high familial risk.",
keywords = "Depression, adolescence, anxiety, inhibitory control, vulnerability",
author = "Stevens, {Elizabeth S.} and Funkhouser, {Carter J.} and Auerbach, {Randy P.} and Ardesheer Talati and Gameroff, {Marc G.} and Posner, {Jonathan E.} and Weissman, {Myrna M.} and Shankman, {Stewart A.}",
note = "Funding Information: This work was supported by the National Institute of Mental Health (grants R01MH036197, R01MH119771, and F31MH123042). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or of any other sponsor. Funding Information: Dr Weissman has received research funding from the Brain and Behavior Foundation and the Templeton Foundation and has received royalties from Perseus Press, Oxford Press, APA Publishing, and Multihealth Systems. Dr Posner has received research funding from Takeda and Aevi Genomics and received a consultancy from Innovation Science. None of these represent a conflict of interest for this paper, and the other authors have no potential conflicts of interest to disclose. Publisher Copyright: {\textcopyright} Wolters Kluwer Health, Inc. All rights reserved.",
year = "2023",
month = feb,
day = "1",
doi = "10.1097/NMD.0000000000001584",
language = "English (US)",
volume = "211",
pages = "100--107",
journal = "Journal of Nervous and Mental Disease",
issn = "0022-3018",
publisher = "Lippincott Williams and Wilkins",
number = "2",
}